Approval · Notice of Compliance 4820 · 2004
CUTIVATE: Notice of Compliance 4820
Issued July 29, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4820
- Date
- July 29, 2004
- Company
- Glaxosmithkline Consumer Healthcare UlcMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Topical anti-inflammatory corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CUTIVATE | 02090015 | — |
| CUTIVATE | 02089912 | Cancelled Post Market |
Medicinal ingredients
- FLUTICASONE PROPIONATE 0.005 PER
- FLUTICASONE PROPIONATE 0.05 PER